Market Value15,269,446,000
Total Holdings115
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CERS / Cerus Corporation
TCRX / TScan Therapeutics, Inc.
ALKS / Alkermes plc
INCY / Incyte Corporation
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
NLTX / Neoleukin Therapeutics, Inc.
REPL / Replimune Group, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
PASG / Passage Bio, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
INSM / Insmed Incorporated
ABCL / AbCellera Biologics Inc.
CABA / Cabaletta Bio, Inc.
MRTX / Mirati Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
OTIC / Otonomy Inc
BCEL / Atreca, Inc.
SGEN / Seagen Inc
IDYA / IDEAYA Biosciences, Inc.
KRTX / Karuna Therapeutics, Inc.
INZY / Inozyme Pharma, Inc.
GBT / Global Blood Therapeutics Inc.
ATRA / Atara Biotherapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
BCAB / BioAtla, Inc.
US46185LAB99 / Invitae Corp
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
ALT / Altimmune, Inc.
US30048L2034 / EVOFEM BIOSCIENCES INC
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
EPZM / Epizyme Inc
NEXI / NexImmune, Inc.
HRTX / Heron Therapeutics, Inc.
FHTX / Foghorn Therapeutics Inc.
AKRO / Akero Therapeutics, Inc.
KRYS / Krystal Biotech, Inc.
STOK / Stoke Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
KYMR / Kymera Therapeutics, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
CINC / CinCor Pharma Inc
VOR / Vor Biopharma Inc.
ATHA / Athira Pharma, Inc.
BLUE / bluebird bio, Inc.
ALGS / Aligos Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
CYTT / Cyteir Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
HRMY / Harmony Biosciences Holdings, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
BMEA / Biomea Fusion, Inc.
FGEN / FibroGen, Inc.
MGNX / MacroGenics, Inc.
FLGT / Fulgent Genetics, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
TCDA / Tricida Inc
US457669AB50 / INSMED INC CONV 0.75% 06/01/2028
ITOS / iTeos Therapeutics, Inc.
KRON / Kronos Bio, Inc.
KZR / Kezar Life Sciences, Inc.
FMTX / Forma Therapeutics Holdings Inc
RLMD / Relmada Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
TRDA / Entrada Therapeutics, Inc.
NKTX / Nkarta, Inc.
PNT / POINT Biopharma Global Inc.
PRLD / Prelude Therapeutics Incorporated
NGM / NGM Biopharmaceuticals, Inc.
VERA / Vera Therapeutics, Inc.
VSTM / Verastem, Inc.
LOGC / ContextLogic Holdings Inc.
SRZN / Surrozen, Inc.
TVTX / Travere Therapeutics, Inc.
CCXI / ChemoCentryx Inc
ALLK / Allakos Inc.
CBAY / CymaBay Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
EIGR / Eiger BioPharmaceuticals, Inc.
VERU / Veru Inc.
TNGX / Tango Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
MRUS / Merus N.V.
IMTX / Immatics N.V.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
VERV / Verve Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc.
DSGN / Design Therapeutics, Inc.
ALEC / Alector, Inc.
ZYME / Zymeworks Inc.
FATE / Fate Therapeutics, Inc.
SERA / Sera Prognostics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
RYTM / Rhythm Pharmaceuticals, Inc.
NRIX / Nurix Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
RVMD / Revolution Medicines, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
OPT / Opthea Limited - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
LIFE / aTyr Pharma, Inc.
DICE / DICE Therapeutics Inc
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
AGLE / Aeglea BioTherapeutics Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
AFMD / Affimed N.V.
LPTX / Leap Therapeutics, Inc.
PACB / Pacific Biosciences of California, Inc.
TARA / Protara Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
ANAB / AnaptysBio, Inc.
TIL / Instil Bio, Inc.
TLIS / Talis Biomedical Corporation
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
SRZNW / Surrozen, Inc. - Equity Warrant
NVTA / Invitae Corporation
BMRN / BioMarin Pharmaceutical Inc.
NTRA / Natera, Inc.
DNLI / Denali Therapeutics Inc.